A comparison of the pharmacological actions of 4-aminopyridine and two of its derivatives in the monkey.
The neuromuscular, cardiovascular and central nervous system stimulating effects of 4-aminopyridine (4-AP), 2,4-diaminopyridine (2,4-DAP) and LF-14 were investigated in the monkey. All these compounds were shown to reverse the stable neuromuscular blockade produced by the intravenous infusion of pancuronium bromide. The doses producing 50% antagonism (ED50) of the pancuronium-induced neuromuscular block were 0.50, 0.54 and 0.71 mg/kg for LF-14, 2,4-DAP and 4-AP respectively. The compounds had only slight cardiovascular effects. In contrast to 4-AP, LF-14 and 2,4-DAP did not reduce the duration of ketamine/diazepam-induced anesthesia, suggesting minimal if any central nervous system effects of these two compounds.
D015761:4-Aminopyridine / Q000031:analogs & derivatives; D000631:Aminopyridines / Q000494:pharmacology*; D000777:Anesthetics; D000818:Animals; D003975:Diazepam / Q000037:antagonists & inhibitors; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007649:Ketamine / Q000037:antagonists & inhibitors; D008254:Macaca nemestrina; D008297:Male; D009467:Neuromuscular Depolarizing Agents / Q000037:antagonists & inhibitors
D000631:Aminopyridines; D000777:Anesthetics; D009467:Neuromuscular Depolarizing Agents; D007649:Ketamine; C040030:LF 14; C026805:2,4-diaminopyridine; D015761:4-Aminopyridine; D003975:Diazepam